Benjamin Lawson, - Medicare Nephrology in Missoula, MT

Benjamin Lawson, is a medicare enrolled "Internal Medicine - Nephrology" physician in Missoula, Montana. He graduated from medical school in 2015 and has 9 years of diverse experience with area of expertise as Nephrology. He is a member of the group practice Providence Health And Services Mt, Providence St Joseph Medical Center and his current practice location is 3055 N Reserve St Ste D, Missoula, Montana. You can reach out to his office (for appointments etc.) via phone at (406) 327-7000.

Benjamin Lawson is licensed to practice in Montana (license number MED-PHYS-LIC-126508) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1154717775.

Contact Information

Benjamin Lawson,
3055 N Reserve St Ste D,
Missoula, MT 59808-1395
(406) 327-7000
(406) 329-1927



Physician's Profile

Full NameBenjamin Lawson
GenderMale
SpecialityNephrology
Experience9 Years
Location3055 N Reserve St Ste D, Missoula, Montana
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Benjamin Lawson graduated from medical school in 2015
  NPI Data:
  • NPI Number: 1154717775
  • Provider Enumeration Date: 04/10/2015
  • Last Update Date: 08/24/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3971896887
  • Enrollment ID: I20230724001294

Medical Identifiers

Medical identifiers for Benjamin Lawson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1154717775NPI-NPPES
K160843MedicaidAK

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RN0300XInternal Medicine - Nephrology MED-PHYS-LIC-126508 (Montana)Primary
207RN0300XInternal Medicine - Nephrology 172648 (Alaska)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Fmc MissoulaMissoula, MTDialysis facility
St. Patrick HospitalMissoula, MTHospital
Providence St Joseph Medical CenterPolson, MTHospital
Providence Alaska Medical CenterAnchorage, AKHospital
Community Hospital Of AnacondaAnaconda, MTHospital
Community Medical CenterMissoula, MTHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Providence Health And Services Mt6608786306272
Providence St Joseph Medical Center044623024740

News Archive

NO-naproxen blocks molecular changes leading to colorectal cancer development

Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.

Toolkits to facilitate implementation of new WHO guidelines for reducing HIV infections issued

At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization recommendations for four technical areas: antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, infant feeding in the context of HIV, and antiretroviral treatment for children, adolescents, and adults.

AACE approves A1c as additional diagnostic criterion for type 2 diabetes

The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.

Oral bacteria may contribute to the development of obesity

The world-wide explosion of overweight people has been called an epidemic. The inflammatory nature of obesity is widely recognized. Could it really be an epidemic involving an infectious agent? In this climate of concern over the increasing prevalence of overweight conditions in our society, investigators have focused on the possible role of oral bacteria as a potential direct contributor to obesity.

Read more Medical News

› Verified 3 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Benjamin Lawson allows following entities to bill medicare on his behalf.
Entity NameProvidence Health & Services Mt
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1144319138
PECOS PAC ID: 6608786306
Enrollment ID: O20031229000787

News Archive

NO-naproxen blocks molecular changes leading to colorectal cancer development

Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.

Toolkits to facilitate implementation of new WHO guidelines for reducing HIV infections issued

At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization recommendations for four technical areas: antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, infant feeding in the context of HIV, and antiretroviral treatment for children, adolescents, and adults.

AACE approves A1c as additional diagnostic criterion for type 2 diabetes

The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.

Oral bacteria may contribute to the development of obesity

The world-wide explosion of overweight people has been called an epidemic. The inflammatory nature of obesity is widely recognized. Could it really be an epidemic involving an infectious agent? In this climate of concern over the increasing prevalence of overweight conditions in our society, investigators have focused on the possible role of oral bacteria as a potential direct contributor to obesity.

Read more Medical News

› Verified 3 days ago

Entity NameProvidence St Joseph Medical Center
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1669655528
PECOS PAC ID: 0446230247
Enrollment ID: O20040910001134

News Archive

NO-naproxen blocks molecular changes leading to colorectal cancer development

Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.

Toolkits to facilitate implementation of new WHO guidelines for reducing HIV infections issued

At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization recommendations for four technical areas: antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, infant feeding in the context of HIV, and antiretroviral treatment for children, adolescents, and adults.

AACE approves A1c as additional diagnostic criterion for type 2 diabetes

The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.

Oral bacteria may contribute to the development of obesity

The world-wide explosion of overweight people has been called an epidemic. The inflammatory nature of obesity is widely recognized. Could it really be an epidemic involving an infectious agent? In this climate of concern over the increasing prevalence of overweight conditions in our society, investigators have focused on the possible role of oral bacteria as a potential direct contributor to obesity.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Benjamin Lawson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Benjamin Lawson,
Po Box 12,
Liberty Lake, WA 99019-0012

Ph: (866) 747-2455
Benjamin Lawson,
3055 N Reserve St Ste D,
Missoula, MT 59808-1395

Ph: (406) 327-7000

News Archive

NO-naproxen blocks molecular changes leading to colorectal cancer development

Past randomized clinical trials have shown that non-steroidal anti-inflammatory drugs (NSAIDs), including naproxen, can reduce the risk of colon cancer and precancerous polyps in humans. Now, researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively common side effect associated with NSAIDs.

Toolkits to facilitate implementation of new WHO guidelines for reducing HIV infections issued

At the XVIII International AIDS Conference, the Elizabeth Glaser Pediatric AIDS Foundation has issued the first of a series of three linked toolkits to facilitate the adaptation and implementation of the revised World Health Organization recommendations for four technical areas: antiretroviral drugs for treating pregnant women and preventing HIV infection in infants, infant feeding in the context of HIV, and antiretroviral treatment for children, adolescents, and adults.

AACE approves A1c as additional diagnostic criterion for type 2 diabetes

The American Association of Clinical Endocrinologists (AACE) today has approved the use of A1c as an additional diagnostic criterion for type 2 diabetes. An A1c of 6.5 or greater is now considered an alternate criterion for the diagnosis of type 2 diabetes.

Oral bacteria may contribute to the development of obesity

The world-wide explosion of overweight people has been called an epidemic. The inflammatory nature of obesity is widely recognized. Could it really be an epidemic involving an infectious agent? In this climate of concern over the increasing prevalence of overweight conditions in our society, investigators have focused on the possible role of oral bacteria as a potential direct contributor to obesity.

Read more News

› Verified 3 days ago


Internal Medicine Doctors in Missoula, MT

Mr. George Bandow, MD
Nephrology
Medicare: Medicare Enrolled
Practice Location: 2809 Great Northern Loop, Suite 200, Missoula, MT 59808
Phone: 406-541-7139    Fax: 406-541-7143
Simone Musco, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 500 W Broadway St, Ste 320, Missoula, MT 59802
Phone: 406-329-5615    
Rolf H O Holle, M.D.
Nephrology
Medicare: Medicare Enrolled
Practice Location: 1782 Elison Ln Unit 3, Missoula, MT 59802
Phone: 406-544-1871    
John David Anthony Lakatua, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 500 West Broadway, Missoula, MT 59802
Phone: 406-721-5600    Fax: 406-721-3907
Mr. Curtis G Wickre, MD
Nephrology
Medicare: Not Enrolled in Medicare
Practice Location: 500 W Broadway St, 4th Floor, Missoula, MT 59802
Phone: 406-327-1900    
Dr. Charlotte Nelson, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 500 W Broadway St, Missoula, MT 59802
Phone: 406-327-1613    
Michele A Danicich, MD
Nephrology
Medicare: Accepting Medicare Assignments
Practice Location: 900 N Orange St Ste 304, Missoula, MT 59802
Phone: 406-329-5781    Fax: 406-327-3331

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.